Literature DB >> 9403745

Propofol 2% in critically ill patients: effect on lipids.

G McLeod1, J Dick, C Wallis, A Patterson, C Cox, J Colvin.   

Abstract

OBJECTIVE: To investigate the concentrations of triglyceride, cholesterol, and high-density lipoprotein during a 50-hr infusion of 2% propofol, starting within 24 hrs of admission to the intensive care unit (ICU).
DESIGN: Prospective, clinical study.
SETTING: ICU, university hospital. PATIENTS: Thirty adult patients, who were ventilated and expected to be sedated for >2 days, were studied for 50 hrs, beginning at 1800 hrs on the first day of ICU admission.
MEASUREMENTS AND MAIN RESULTS: Triglyceride, cholesterol, and high-density lipoprotein were measured at 2000, 0400, and 0800 hrs. Tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and C-reactive protein were measured at 2000 hrs. Median cholesterol and high-density lipoprotein concentrations were at the low end of the normal range. In seven patients, peak triglyceride concentrations were >3 mmol/L up to a maximum of 4.83 mmol/L. Although there was no statistical difference in lipid concentrations between days 1 and 2, there was an apparent pattern of increasing triglyceride concentrations. There was a correlation between peak triglyceride concentration and total propofol consumption, but there was no correlation between lipids and age, gender, or Acute Physiology and Chronic Health Evaluation II scores. There was a direct correlation between triglyceride and C-reactive protein concentrations, and an inverse correlation between cholesterol and C-reactive protein. Twenty-two patients had evidence of TNF and 11 patients had an IL-6 of >1000 pg/mL, but there was no relationship between concentrations of cytokines and triglycerides in plasma.
CONCLUSIONS: Infusion of 2% propofol to critically ill patients over a 50-hr period does not result in a significant increase in triglyceride concentrations. Mean cholesterol and high-density lipoprotein concentrations were low throughout the study period. There was a significant direct correlation between triglyceride and C-reactive protein and an inverse correlation between cholesterol and C-reactive protein, suggesting that the changes in lipids in critically ill patients may be partly attributable to the acute-phase response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403745     DOI: 10.1097/00003246-199712000-00012

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Hypertriglyceridemia: a potential side effect of propofol sedation in critical illness.

Authors:  J-C Devaud; M M Berger; A Pannatier; P Marques-Vidal; L Tappy; N Rodondi; R Chiolero; P Voirol
Journal:  Intensive Care Med       Date:  2012-09-28       Impact factor: 17.440

Review 2.  Propofol: a review of its use in intensive care sedation of adults.

Authors:  Kate McKeage; Caroline M Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  Postoperative analgesia and sedation in the adult intensive care unit: a guide to drug selection.

Authors:  Linda L Liu; Michael A Gropper
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol.

Authors:  Mary P Kovacevic; Kevin M Dube; Kenneth E Lupi; Paul M Szumita; Jeremy R DeGrado
Journal:  Crit Care Explor       Date:  2021-01-11

5.  The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors.

Authors:  Michael J Corrado; Mary P Kovacevic; Kevin M Dube; Kenneth E Lupi; Paul M Szumita; Jeremy R DeGrado
Journal:  Crit Care Explor       Date:  2020-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.